Shodhana Laboratories, a WHO GMP, ISO 9001-2008 and ISO 14000:2004 certified company, headquartered at Hyderabad, was established in the year 2000 by a Technocrat and a Doctorate in Chemistry (Dr. Giridhar Thota) who has more than 35 years of rich industrial experience. We are in to manufacturing of APIs and intermediates. Our facility is approved by KFDA (Korea), COFEPRIS (Mexico) and TGA (Australia). Our current reaction volume is about 350kL. We are one of the largest manufacturers of Carvedilol intermediates (4- Hydroxy Carbazole) in India and one of the largest manufacturers of Rivastigime API in the world. We have CEP approvals for 4 of our APIs - Carvedilol, Citalopram HBr, Duloxetine HCl, Ondansetron HCl, Rivastigmine base (CEP is under review), a UK DMF for Citalopram Hydrobromide and a USDMF for Duloxetine. We also filed DMF for Rivastigmine base in over 30 European countries. We have filed 11 Indian Patent applications, 3 US patent applications and 6 PCT applications (Including one novel polymorph). We have an efficient team of about 30 R&D scientists, who have good expertise in process development and scale up. We have a proven track record of Custom Chemical Synthesis. We have already developed products for US, Europe and Australian markets and provided them with gram level quantities to hundred kilogram quantities. Our motto is to achieve “Customer Satisfaction” by offering reliable products within scheduled time frame, supporting the Manufacturers (Pre-Sale& Post Sale) with necessary documentation.